Related Experiment Video
Updated: Jul 23, 2025
09:25
An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats
Published on: May 8, 2020
8.0K
Liquid Biopsy, a Potential New Detection Method in Heart Allograft Rejection
1Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Methods in Molecular Biology (Clifton, N.J.)
|July 14, 2023
Summary
Graft rejection is a major issue in heart transplants. Liquid biopsy offers a cheaper, noninvasive alternative to endomyocardial biopsy for detecting rejection in transplant recipients.
Area of Science:
- Cardiovascular Surgery
- Immunology
- Molecular Diagnostics
Background:
- Allograft rejection is the primary cause of graft dysfunction in heart transplant recipients.
- Endomyocardial biopsy (EMB) is the current gold standard for diagnosing rejection but is invasive.
- Minimally invasive and noninvasive monitoring methods are needed to improve patient outcomes.
Approach:
- This review explores various liquid biopsy techniques, including droplet-based digital PCR and next-generation sequencing.
- The application of these noninvasive methods in heart transplantation is discussed.
- Cost-effectiveness compared to traditional endomyocardial biopsy is highlighted.
Key Points:
- Liquid biopsy offers a promising noninvasive approach for monitoring heart transplant recipients.
- Advancements in digital PCR and NGS technologies enhance the sensitivity and specificity of liquid biopsy.
- This technique provides a potentially cheaper and safer alternative to serial endomyocardial biopsies.
Conclusions:
- Liquid biopsy represents a significant advancement in the noninvasive surveillance of heart transplant allografts.
- Its adoption could lead to earlier detection of rejection and improved long-term graft survival.
- Further research and clinical validation are essential to fully integrate liquid biopsy into standard heart transplant care.
